During these months of emergency, DataRiver provided support for data cleaning and data integration of several facilities at the forefront of the fight against COVID-19.
Data of patients with serious respiratory complications from Struttura Complessa di Malattie Infettive – Azienda Ospedaliera Universitaria di Modena, Unità Operativa di Malattie Infettive e Dipartimento di Reumatologia dell’IRCSS di Reggio Emilia as well as Unità Operativa di Malattie Infettive del Policlinico S.Orsola-Malpighi, were integrated and collected in the retrospective study “Tocilizumab in patients with severe COVID-19: a retrospective cohort study“.
A first outcome was recently published by the international journal The Lancet – Rheumatology:
https://www.thelancet.com/journals/lhe/article/PIIS2665-9913(20)30173-9/fulltext
